COMMUNIQUÉS West-GlobeNewswire

International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018
22/05/2018
CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Trevena announces presentations at the American Society of Colon and Rectal Surgeons 2018 Annual Scientific Meeting
22/05/2018
New colorectal surgery data presented from the oliceridine ATHENA Phase 3 open label safety study CHESTERBROOK, Pa., May 22, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced two presentations at [...]
Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
22/05/2018
Revolutionary “smart” drug could prevent hypoglycemia in people with diabetes BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Protomer Technologies of Pasadena, CA, will receive $50,000 in cash and up to $150,000 of in-kind [...]
Transactions in relation to share buyback program
22/05/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Terveystalo Plc: Managers' Transactions
22/05/2018
TERVEYSTALO PLC MANAGERS' TRANSACTIONS 22 May 2018 at 13:40 EEST ____________________________________________ Person subject to the notification requirement Name: Rettig Group AB Position: Closely associated person (X) [...]
Avivagen Announces Drawdown from Credit Facility
22/05/2018
OTTAWA, May 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTCPink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
RavenQuest Provides Corporate Update
22/05/2018
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce the appointment of Lisa MacNeil as [...]
Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on June 05th, 2018
22/05/2018
Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on June 05th, 2018 : 1. Report of the Board on results of operations in 2017. Draft resolution: To take notice of the Report [...]
Zealand grants new warrants under employee warrant program
22/05/2018
Company announcement - No. 15/2018 Zealand grants new warrants under employee warrant program Copenhagen, May 22, 2018 - Zealand Pharma ("Zealand") announces the granting of warrants to the Company's Executive [...]
Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute
22/05/2018
Data published in Nature Communications show MDM2 and MDMX are targetable vulnerabilities within TP53-wild-type T-cell Lymphomas CAMBRIDGE, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), [...]
FIT Biotech Oy: Positive results from gene therapy collaboration with Avacta
22/05/2018
FIT Biotech Oy Company release 22.5.2018 at 9.30 EET Positive results from gene therapy collaboration with Avacta FIT Biotech Oy ("FIT Biotech", FITBIO:FN Finland) today announced that the results from a preclinical [...]
Enzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus
22/05/2018
Press release Lund May 22, 2018 Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus Enzymatica has entered into a distribution agreement with Qualia Pharma for marketing and sales of ColdZyme® Mouth [...]
Nexstim Plc - first NBT® system for depression ordered in the US
22/05/2018
Company announcement, Helsinki, 22 May 2018, at 9:00 AM Nexstim Plc - first NBT® system for depression ordered in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company [...]
Shire plc : Rule 2.9 Announcement
22/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 22 May 2018 Shire [...]
SHIRE RELEASES DATA AT THE WFH CONGRESS 2018 EVALUATING VONVENDI® IN ADULTS WITH VON WILLEBRAND DISEASE DURING AND AFTER SURGERY
22/05/2018
P SHIRE RELEASES DATA AT THE WORLD FEDERATION OF HEMOPHILIA CONGRESS 2018 EVALUATING VONVENDI ® [VON WILLEBRAND FACTOR (RECOMBINANT)] IN ADULTS WITH VON WILLEBRAND DISEASE DURING AND AFTER SURGERY - Study evaluated [...]
Spark Therapeutics and Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events
22/05/2018
Annualized bleeding rate (ABR) for all 15 participants was reduced by 98 percent, while annualized infusion rate (AIR) was reduced by 99 percent as of the May 7, 2018 data cutoff Range of steady-state factor IX activity [...]
Sensorion Appoints Professor Christine Petit, MD, PhD as Chair of its Scientific Advisory Board
22/05/2018
Internationally-renowned geneticist and neurobiologist with decades of hearing research leadership to head Sensorion’s Scientific Advisory Board MONTPELLIER, France, May 22, 2018 (GLOBE NEWSWIRE) -- Sensorion ( [...]
MDxHealth (R): Presentation of New Data on MDxHealth's Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting
22/05/2018
NEWS RELEASE Moderated posters and oral presentations feature clinical and health economic validations of SelectMDx, ConfirmMDx and prospective clinical validation of AssureMDx IRVINE, CA, and HERSTAL, BELGIUM - 07.00 [...]
MDxHealth (R) :
22/05/2018

Pages